NCT01724294 An Observational Study of MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in First-Line in Patients With Diffuse Large B-Cell Lymphoma Status TERMINATED Phase N/A
NCT01724021 A Study of Participant Preference With Subcutaneous Versus Intravenous MabThera/Rituxan in Participants With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2 or 3a Status COMPLETED Phase PHASE3
NCT01723878 ASPET Study: An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced Non-Small Cell Lung Cancer Harbouring EGFR Activating Mutations Status COMPLETED Phase N/A
NCT01716559 An Observational Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Non-myeloid Malignancy Status COMPLETED Phase N/A
NCT01715909 A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza Infection Status COMPLETED Phase PHASE1
NCT01715831 A Long-term Safety Extension Study of Tocilizumab in Brazilian Participants With Rheumatoid Arthritis (RA) Who Completed the Studies ML21530 and MA21488 Status COMPLETED Phase PHASE4
NCT01715818 A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities Status COMPLETED Phase PHASE3
NCT01714154 A Safety And Pharmacokinetic Study of Setrobuvir Alone and In Combination With Ritonavir-Boosted Danoprevir in Subjects With Mild Hepatic Impairment Compared to Healthy Controls Status COMPLETED Phase PHASE1
NCT01712347 An Observational Study of First-Line Bevacizumab (Avastin) With Fluoropyrimidine-Based Chemotherapy in Participants With Metastatic Colorectal Cancer Status COMPLETED Phase N/A
NCT01711801 A Study of Safety, Pharmacokinetics (Including Food Effect) And Pharmacodynamics of RO5545965 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01711775 A Pharmacokinetic Study of Aleglitazar in Healthy Chinese Volunteers Status COMPLETED Phase PHASE1
NCT01708616 A Study of the Combination of Multiple Doses of RO5285119 With a Single Dose of Risperidone in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01707550 An Observational Study of CellCept (Mycophenolate Mofetil) in Renal Allograft Recipients Status COMPLETED Phase N/A
NCT01706575 A Study of Pegasys (Peginterferon Alfa-2a) Added to Nucleos(t)Ide Analogue Treatment in Participants With HBeAg-Negative Chronic Hepatitis B Genotype D Showing Stable Hepatitis B Virus (HBV) Deoxyribonucleic Acid (DNA) Suppression Status COMPLETED Phase PHASE2
NCT01705730 A Non-Interventional Study of Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) in Monotherapy Status COMPLETED Phase N/A
NCT01705717 A Retrospective Study of Real World Treatment Outcomes of Patients With Chronic Hepatitis C Status COMPLETED Phase N/A
NCT01705704 A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B Status COMPLETED Phase N/A
NCT01702714 A Study of RO5083945 in Combination With Cisplatin and Gemcitabine or Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer of Squamous Histology Who Have Not Received Prior Chemotherapy for The Metastatic Disease Status WITHDRAWN Phase PHASE1
NCT01702571 A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment Status COMPLETED Phase PHASE3
NCT01702558 A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC) Status TERMINATED Phase PHASE2